Bioinspired vaccines to enhance MHC class-I antigen cross-presentation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bioinspired vaccines to enhance MHC class-I antigen cross-presentation

Published:2022-08 Issue: Volume:77 Page:102215
ISSN:0952-7915
Container-title:Current Opinion in Immunology
language:en
Short-container-title:Current Opinion in Immunology

Author:

Baljon Jessalyn J,Wilson John T

Funder

National Science Foundation

National Institutes of Health

U.S. Department of Veterans Affairs

Susan G. Komen

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference75 articles.

1. Intracellular pathogens: host immunity and microbial persistence strategies;Thakur;J Immunol Res,2019

2. Virus-specific CD8 T cells: activation, differentiation and memory formation;Wiesel;APMIS,2009

3. A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion;Dersh;Nat Rev Immunol,2021

4. CD8(+) T cells: foot soldiers of the immune system;Zhang;Immunity,2011

5. Advances in the development of personalized neoantigen-based therapeutic cancer vaccines;Blass;Nat Rev Clin Oncol,2021

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-pronged anti-cancer nanovaccines enpowered by exogenous/endogenous tumor-associated antigens;Journal of Controlled Release;2024-09

2. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists;ACS Nano;2024-02-22

3. The XCL1-Mediated DNA Vaccine Targeting Type 1 Conventional Dendritic Cells Combined with Gemcitabine and Anti-PD1 Antibody Induces Potent Antitumor Immunity in a Mouse Lung Cancer Model;International Journal of Molecular Sciences;2024-02-04

4. Cancer cell membrane proteins-encapsulated nanovaccine enhances cancer immunotherapy and prevention by provoking antigen-specific cellular immunity via the dendritic cell-targeted delivery;Chemical Engineering Journal;2024-02

5. Antigen cross-presentation in dendric cells: From bench to bedside;Biomedicine & Pharmacotherapy;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3